| Entry |
|
|---|
| Name |
Pamidronic acid (INN);
Ribodroat (TN) |
|---|
| Formula |
C3H11NO7P2
|
|---|
| Exact mass |
235.0011
|
|---|
| Mol weight |
235.0695
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
|
|---|
| Remark |
| Product (DG00782): | D00941<JP/US> |
|
|---|
| Efficacy |
Antiresorptive, Farnesylpyrophosphate synthetase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA03 Pamidronic acid
D07281 Pamidronic acid (INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00782 Pamidronic acid
D07281 Pamidronic acid
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Alkyl/Aryl transferases
FDPS
D07281 Pamidronic acid (INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00782 Pamidronic acid
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 13
1 C1d C 24.0800 -18.7600
2 P1b P 22.5400 -18.7600
3 P1b P 25.8300 -18.7600
4 C1b C 24.0800 -17.6400
5 O1a O 24.0800 -20.1600
6 O1c O 21.1400 -18.7600
7 O1c O 22.5400 -20.1600
8 O1c O 22.5400 -17.2900
9 O1c O 25.8300 -20.2300
10 O1c O 25.8300 -17.2200
11 O1c O 27.1600 -18.7600
12 C1b C 25.0600 -17.1500
13 N1a N 25.0600 -15.6800
BOND 12
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 2 7 1
7 2 8 2
8 3 9 1
9 3 10 2
10 3 11 1
11 4 12 1
12 12 13 1
|
|---|
